Innovations in the management of Wilms’ tumor

Therapeutic Advances in Urology

Volumn 6, Issue 4, 2014, Pages 165-176

  Gleason, Joseph M ^a   Lorenzo, Armando J ^a   Bowlin, Paul R ^a   Koyle, Martin A ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

innovations; minimally invasive; nephron sparing; Wilms tumor

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; VINCRISTINE;

CANCER CHEMOTHERAPY; CANCER STAGING; HEALTH CARE QUALITY; HISTOLOGY; HUMAN; KIDNEY TUMOR; MORBIDITY; NEPHROBLASTOMA; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE;

EID: 84902469790     PISSN: 17562872     EISSN: 17562880     Source Type: Journal    
DOI: 10.1177/1756287214528023     Document Type: Review

References (47)

1. Barber T. Wickiser J. Wilcox D. Baker L. (2009) Prechemotherapy laparoscopic nephrectomy for Wilms– tumor. J Pediatr Urol 5: 416–419.
2. Breslow N. Beckwith J. Ciol M. Sharples K. (1988) Age distribution of Wilms– tumor: report from the National Wilms– Tumor Study. Cancer Res 48: 1653–1657.
3. Breslow N. Beckwith J. Perlman E. Reeve A. (2006) Age distributions, birth weights, nephrogenic rests, and heterogeneity in the pathogenesis of Wilms tumor. Pediatr Blood Cancer 47: 260–267.
4. Breslow N. Lange J. Friedman D. Green D. Hawkins M. Murphy M. (2010). Secondary malignant neoplasms after Wilms tumor: an international collaborative study. Int J Cancer 127: 657–666.
5. Chui C. Lee A. (2011) Peritoneal metastases after laparoscopic nephron-sparing surgery for localized Wilms tumor. J Pediatr Surg 46: e19–e21.
6. Coresh J. Selvin A. Stevens L. Manzi J. Kusek J. Eggers P. (2007) Prevalence of chronic kidney disease in the United States. JAMA 298: 2038–2047.
7. Cost N. Lubahn J. Granberg C. Schlomer B. Wickiser J. Rakheja D. (2012) Oncologic outcomes of partial versus radical nephrectomy for unilateral Wilms tumor. Pediatr Blood Cancer 58: 898–904.
8. Cotton C. Peterson S. Norkool P. Takashima J. Grigoriev Y. Green D. (2009) Early and late mortality after diagnosis of Wilms tumor. J Clin Oncol 27: 1304–1309.
9. Craft A. Parker L. Stiller C. Cole M. (1995) Screening for Wilms– tumour in patients with aniridia, Beckwith syndrome, or hemihypertrophy. Med Pediatr Oncol 24: 231–234.
10. Davidoff A. (2012) Wilms tumor. Adv Pediatr 59: 247–267.
11. Dome J. Cotton C. Perlman E. Breslow N. Kalapurakal J. Ritchey M. (2002) Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children–s Research Hospital. J Pediatr Hematol Oncol 24: 192–198.
12. Duarte R. Denes F. Cristofani M. Srougi M. (2009) Laparoscopic nephrectomy for Wilms– tumor. Exp Rev Anticancer Ther 9: 753–761.
13. Dumoucel S. Gauthier-Villars M. Stoppa-Lyonnet M. Parisot P. Brisse H. Philippe-Chomette P. (2014) Malformations, genetic abnormalities, and Wilms tumor. Pediatr Blood Cancer 61: 140–144.
14. Ferrer F. Rosen N. Herbst K. Fernandez C. Khanna G. Dome J. (2013) Image based feasibility of renal sparing surgery for very low risk unilateral wilms tumors: a report from the Children–s Oncology Group. J Urol 190: 1846–1851.
15. Green D. (2013) The evolution of treatment for Wilms tumor. J Pediatr Surg 48: 14–19.
16. Green D. Breslow N. Beckwith J. Norkool P. (1993) Screening of children with hemihypertrophy, aniridia, and Beckwith-Wiedemann syndrome in patients with Wilms tumor: a report from the National Wilms Tumor Study. Med Pediatr Oncol 21: 188–192.
17. Green D. Breslow N. Beckwith J. Ritchey M. Shamberger R. Haase G. (2001) Treatment with nephrectomy only for small, stage I/favorable histology Wilms– tumor: a report from the National Wilms– Tumor Study Group. J Clin Oncol 19: 3719–3724.
18. Griffiths-Jones S. Saini H. van Dongen S. Enright A. (2007) miRBase: tools for microRNA genomics. Nucl Acids Res 36: D154–D158.
19. Grundy P. Breslow N. Li S. Perlman E. Beckwith J. Ritchey M. (2005) Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group. J Clin Oncol 23: 7312–7321.
20. Haecker F. von Schweinitz D. Harms D. Buerger D. Graf N. (2003) Partial nephrectomy for unilateral Wilms tumor: results of study SIOP 93–01/GPOH. J Urol 170: 939–942; discussion 943–944.
21. Hamilton T. Green D. Perlman E. Argani P. Grundy P. Ritchey M. (2006) Bilateral Wilms– tumor with anaplasia: lessons from the National Wilms– Tumor Study. J Pediatr Surg 41: 1641–1644.
22. Jairam V. Roberts K. Yu J. (2013) Historical trends in the use of radiation therapy for pediatric cancers: 1973–2008. Int J Radiat Oncol Biol Phys 85: e151–e155.
23. Kieran K. Anderson J. Dome J. Ehrlich P. Ritchey M. Shamberger R. (2013) Is adrenalectomy necessary during unilateral nephrectomy for Wilms Tumor? A report from the Children–s Oncology Group. J Pediatr Surg 48: 1598–1603.
24. Kraushaar G. Wiebe S. (2005) Renal cell carcinoma as a second malignant neoplasm in a patient with non-syndromic hemihypertrophy and previous Wilms tumor. Pediatr Radiol 35: 1208–1211.
25. Lange J. Peterson S. Takashima J. Grigoriev Y. Ritchey M. Shamberger R. (2011) Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor. J Urol 186: 378–386.
26. Lazarus J. Moolman C. (2009) Renal cell carcinoma as second malignancy in patient with previous Wilms tumor. Urology 74: 598–600.
27. McNeil D. Brown M. Ching A. DeBaun M. (2001) Screening for Wilms– tumor and hepatoblastoma in children with Beckwith-Wiedemann syndromes: a cost-effective model. Med Pediatr Oncol 37: 349–356.
28. Milose J. Filson C. Weizer A. Hafez K. Montgomery J. (2011) Role of biochemical markers in testicular cancer: diagnosis, staging, and surveillance. Open Access J Urol 4: 1–8.
29. Mitchell C. Pritchard-Jones K. Shannon R. Hutton C. Stevens S. Machin D. (2006) Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms– tumour: results of a randomised trial (UKW3) by the UK Children–s Cancer Study Group. Eur J Cancer 42: 2554–2562.
30. Moore K. Leslie B. Salle J. Braga L. Bagli D. Bolduc S. (2010) Can we spare removing the adrenal gland at radical nephrectomy in children with wilms tumor? J Urol 184(4 Suppl.): 1638–1643.
31. Ng A. Griffiths A. Cole T. Davison V. Griffiths M. Larkin S. (2007) Congenital abnormalities and clinical features associated with Wilms– tumour: a comprehensive study from a centre serving a large population. Eur J Cancer 43: 1422–1429.
32. Novick A. Streem S. Montie J. Pontes J. Siegel S. Montague D. (1989) Conservative surgery for renal cell carcinoma: a single-center experience with 100 patients. J Urol 141: 835–839.
33. Perlman E. Grundy P. Anderson J. Jennings L. Green D. Dome J. (2011) WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children–s oncology group study. J Clin Onncol 29: 698–703.
34. Piotrowski Z. Canter D. Kutikov A. Al-Saleem T. Pei J. Testa J. (2010) Metanephric adenofibroma: robotic partial nephrectomy of a large Wilms– tumor variant. Can J Urol 17: 5309–5312.
35. Rich B. McEvoy M. Quaglia M. (2010) A case of renal cell carcinoma after successful treatment of Wilms tumor. J Pediatr Surg 45: 1883–1886.
36. Romão R. Salle J. Shuman C. Weksberg R. Figueroa V. Weber B. (2012) Nephron sparing surgery for unilateral Wilms tumor in children with predisposing syndromes: single center experience over 10 years. J Urol 188(4 Suppl.): 1493–1498.
37. Rowe D. Kayton M. O–Toole K. Ingram M. Stolar C. Kandel J. (1999) Pathological angiogenesis in a murine model of human Wilms– tumor. J Pediatr Surg 34: 676–679.
38. Sadak K. Ritchey M. Dome J. (2013) Paediatric genitourinary cancers and late effects of treatment. Nat Rev Urol 10: 15–25.
39. Santana V. Zamboni W. Kirstein M. Tan M. Liu T. Gajjar A. (2003) A pilot study of protracted topotecan dosing using a pharmacokinetically guided dosing approach in children with solid tumors. Clin Cancer Res 9: 633–640.
40. Shamberger R. Anderson J. Breslow N. Perlman E. Beckwith J. Ritchey M. (2010) Long-term outcomes for infants with very low risk Wilms tumor treated with surgery alone in National Wilms Tumor Study-5. Ann Surg 251: 555–558.
41. Smaldone M. Kutikov A. Egleston B. Simhan J. Canter D. Teper E. (2012) Assessing performance trends in laparoscopic nephrectomy and nephron-sparing surgery for localized renal tumors. Urology 80: 286–291.
42. Termuhlen A. Tersak J. Liu Q. Yasui Y. Stovall M. Weathers R. (2011) Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer 57: 1210–1216.
43. Venkatramani R. Malogolowkin M. Davidson T. May W. Sposto R. Mascarenhas L. (2013) A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors. PLoS One 8: e68416.
44. Vujanić G. Kelsey A. Mitchell C. Shannon R. Gornall P. (2003) The role of biopsy in the diagnosis of renal tumors of childhood: results of the UKCCSG Wilms tumor study 3. Med Pediatr Oncol 40: 18–22.
45. Wang J. Wang L. Zhang D. Fan Y. Jia Z. Qin P. (2012) Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors. Mol Biol Rep 39: 5095–5104.
46. Watson J. Bryan K. Williams R. Popov S. Vujanic G. Coulomb A. (2013) miRNA profiles as a predictor of chemoresponsiveness in Wilms– tumor blastema. PloS One 8: e53417.
47. Wright J. (1988) Update in cancer chemotherapy: genitourinary tract cancer, Part 2: Wilms– tumor and bladder cancer. J Natl Med Assoc 80: 169–181.